Prognostic significance of P-wave morphology in patients with coronary artery disease

Santeri Nortamo1, Idamaria Laitinen1, Jussi Passi1

  • 1Research Unit of Internal Medicine, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.

Insights

P-wave morphology parameters like P-wave residuum and duration independently predict sudden cardiac arrest (SCA) in coronary artery disease (CAD) patients. These findings improve risk prediction models for SCA in this population.

Area of Science:

  • Cardiology
  • Electrocardiography
  • Predictive Medicine

Background:

  • The prognostic value of P-wave morphology in coronary artery disease (CAD) patients remains unclear.
  • Sudden cardiac arrest (SCA) is a significant concern in patients with CAD.

Purpose of the Study:

  • To investigate the prognostic significance of P-wave morphology in predicting SCA in patients with CAD.
  • To determine if P-wave parameters can improve existing risk prediction models for SCA.

Main Methods:

  • Analysis of P-wave morphology in 1797 patients with angiographically verified CAD from the ARTEMIS study.
  • Univariate and multivariate analyses were performed to assess the association between P-wave parameters (PWR, PWH, Pdur) and outcomes like SCA.
  • P-wave parameters were added to a clinical risk model to evaluate improvements in discrimination and reclassification accuracy.

Main Results:

  • Absolute P-wave residuum (PWR), P-wave heterogeneity (PWH), and P-wave duration (Pdur) were significantly associated with the risk of SCA.
  • These parameters remained independent predictors of SCA even after adjusting for traditional risk factors.
  • Incorporating P-wave parameters into a clinical risk model significantly improved its discrimination and reclassification accuracy, increasing the C-index from 0.745 to 0.787.

Conclusions:

  • P-wave morphology parameters independently predict SCA in patients with CAD.
  • These ECG findings offer valuable prognostic information beyond traditional risk factors.
  • P-wave analysis can enhance the accuracy of SCA risk stratification in CAD patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
333